Research Summary

Analyzed using Evidence Intelligence™

Metformin may prevent metabolic decline in patients with obstructive sleep apnea

Last updated August 16, 2026

Key finding

Whole body insulin sensitivity (Matsuda index) did not change in metformin or placebo treated groups.

This study investigated the effects of metformin on glucose metabolism and mitochondrial function in patients with obstructive sleep apnea, finding improvements in mitochondrial capacity with metformin treatment.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Medium-Term (3–12 mo)

Risk of bias

Some Concerns

Save research, organize studies, and quickly find important evidence again.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

Clinical relevance

Understanding the effects of metformin on mitochondrial function is crucial for managing patients with obstructive sleep apnea, as it may provide insights into improving metabolic health. Enhanced mitochondrial function could lead to better energy utilization in muscles, potentially benefiting patients' overall health and quality of life.

Keep in mind

The study had a limited sample size. Results may not be generalizable to all patients with obstructive sleep apnea. The duration of treatment may not reflect long-term effects.

Published in

Journal Reference

Publication details and source links for this paper.

Elizabeth RMZ, Elizabeth CH, Wagner SD, et al. Effects of Metformin on Glucose Metabolism and Skeletal Muscle Mitochondrial Function in Patients with Obstructive Sleep Apnea. Physiological Reports. 2024;12(3):e15948. doi:10.14814/phy2.15948

View DOI View on PubMed View on PMC

Main Effects

Whole body insulin sensitivity (Matsuda index) did not change in either group.

Insulin AUC increased in the placebo group but remained unchanged with metformin.

Metformin improved skeletal muscle mitochondrial respiratory capacity.

Metformin improved skeletal muscle mitochondrial dynamics.

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Metformin and Insulin sensitivity, Skeletal muscle mitochondrial respiratory capacity.

This study contributes evidence to

Intervention

Metformin

Outcome

Insulin sensitivity

Evidence topic

Insulin Resistance

Primary intervention

Metformin

Primary outcomes

Insulin sensitivity
Skeletal muscle mitochondrial respiratory capacity

Evidence topics

Insulin Resistance Prediabetes Metformin

Primary intervention

Metformin

Primary outcomes

Insulin sensitivity Skeletal muscle mitochondrial respiratory capacity

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

Evidence pairs

Relationships

Evidence topics

contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 60

Why it is useful

Contributes to 2 evidence relationships
Includes primary outcome data
Linked to 3 direct semantic evidence topics

Topic contributions

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Add related evidence to your Evidence Tracker

Save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.

Primary evidence

Evidence relationship

Metformin Therapies and Insulin Resistance

Related evidence

Evidence topic

Insulin Resistance

Save evidence

Evidence topic

Prediabetes

Save evidence

Core evidence

Study findings

The primary outcomes reported in this study.

Insulin sensitivity

Metformin → Insulin sensitivity

Evidence Intelligence™

EvidenceScore™: Moderate; Score 69 · Based on 2 studies
ImpactScore™: 75; Positive
ConsistencyScore™: 35; mixed

Based on 2 studies

Add to Evidence Tracker

Skeletal muscle mitochondrial respiratory capacity

Metformin → Skeletal muscle mitochondrial respiratory capacity

Evidence Intelligence™

EvidenceScore™: Emerging; Score 59 · Based on 1 study
ImpactScore™: 100; Very Positive
ConsistencyScore™: unclear; Not enough independent studies

Based on 1 study

Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Evidence Suggest

Metformin improved skeletal muscle mitochondrial respiratory capacity.
Insulin AUC increased in the placebo group, indicating a potential negative effect of placebo.
No change in whole body insulin sensitivity was observed in either treatment group.

Who this applies to

Adults diagnosed with obstructive sleep apnea.
Patients with metabolic concerns related to energy utilization.

Keep in Mind

The findings are based on a specific patient population and may not apply universally.
The study did not assess long-term effects of metformin treatment.
Further research is needed to explore the clinical significance of improved mitochondrial function.

Between the Lines

The study had a limited sample size.
Results may not be generalizable to all patients with obstructive sleep apnea.
The duration of treatment may not reflect long-term effects.

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on Metformin Therapies and Postprandial and OGTT Glucose, Metformin Therapies and Insulin Resistance.

Related evidence relationships

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Medications

Detailed evidence

Metformin Therapies → Postprandial and OGTT Glucose

Medications

Evidence Intelligence™

EvidenceScore™: 83; Strong
ImpactScore™: 71; Positive
ConsistencyScore™: 75; consistent

Based on 6 studies

View evidence

Medications

Detailed evidence

Metformin Therapies → Insulin Resistance

Medications

Evidence Intelligence™

EvidenceScore™: Moderate; Score 69 · Based on 2 studies
ImpactScore™: 75; Positive
ConsistencyScore™: 35; mixed

Based on 2 studies

View evidence

Included in these evidence collections

Curated evidence collections and hubs this study is part of.

Metformin Therapies Evidence Hub

All studies on Metformin Therapies

6 studies

intervention_hub

Contributes to Metformin Therapies evidence base.

Postprandial and OGTT Glucose Evidence Hub

All studies measuring Postprandial and OGTT Glucose

6 studies

outcome_hub

Measures Postprandial and OGTT Glucose as a key outcome.

Insulin Resistance Evidence Hub

All studies measuring Insulin Resistance

2 studies

outcome_hub

Measures Insulin Resistance as a key outcome.

Recent Diabetes Research

Latest published studies

recency_collection

Published within the last 2 years.

Explore more in Evidence Explorer

Jump to pre-filtered views in Evidence Explorer.

All studies on Metformin and Glucose iAUC (OGTT)

Intervention: MetforminOutcome: Glucose iAUC (OGTT)

6 results

All studies on Metformin and Insulin sensitivity

Intervention: MetforminOutcome: Insulin sensitivity

2 results

All studies on Metformin

Intervention: Metformin

6 results

All studies measuring Glucose iAUC (OGTT)

Outcome: Glucose iAUC (OGTT)

6 results

All studies measuring Insulin sensitivity

Outcome: Insulin sensitivity

2 results

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Do Metformin Therapies improve insulin resistance?

Strong Evidence

Metformin Therapies may improve insulin resistance.

ConsistencyScore™: Results are generally consistent across studies.

Ranked evidence signals

1
Insulin sensitivity
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 1 study

Why this answer: This answer is based on 7 supporting studies with generally consistent results and a positive effect signal.

View Full Evidence

Does Metformin improve skeletal muscle mitochondrial respiratory capacity?

Emerging Evidence

Metformin appears to improve skeletal muscle mitochondrial respiratory capacity.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

1
Skeletal muscle mitochondrial respiratory capacity
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

Only one supporting study is available.

View Full Evidence

Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

Evidence topics

Follow the topics this study contributes to.

Insulin Resistance Evidence Hub Prediabetes Evidence Hub Metformin Evidence Hub

Explore in Evidence Explorer

Open broader Evidence Explorer views for this relationship.

All studies on Metformin and Insulin sensitivity All studies on Metformin and Skeletal muscle mitochondrial respiratory capacity

Related research

Read related research summaries.

Dietary Modulation of Gut Microbiota in Prediabetes Vildagliptin and Metformin Improve Glycemic Control in Type 2 Diabetes Early use of effective therapies may improve diabetes outcomes Premeal metformin improves postmeal glucose control in diabetes.Metformin does not increase SGA risk in gestational diabetes

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.